These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Role of extracellular domain dimerization in agonist-induced activation of natriuretic peptide receptor A. Parat M; McNicoll N; Wilkes B; Fournier A; De Léan A Mol Pharmacol; 2008 Feb; 73(2):431-40. PubMed ID: 17965196 [TBL] [Abstract][Full Text] [Related]
23. Microbial polysaccharide, HS-142-1, competitively and selectively inhibits ANP binding to its guanylyl cyclase-containing receptor. Morishita Y; Sano T; Ando K; Saitoh Y; Kase H; Yamada K; Matsuda Y Biochem Biophys Res Commun; 1991 May; 176(3):949-57. PubMed ID: 1674870 [TBL] [Abstract][Full Text] [Related]
24. Biological receptors mediate anti-proliferative action of atrial natriuretic peptide in cultured mesangial cells. Haneda M; Kikkawa R; Koya D; Sakamoto K; Nakanishi S; Matsuda Y; Shigeta Y Biochem Biophys Res Commun; 1993 Apr; 192(2):642-8. PubMed ID: 8387284 [TBL] [Abstract][Full Text] [Related]
25. Atrial natriuretic peptide-dependent photolabeling of a regulatory ATP-binding site on the natriuretic peptide receptor-A. Joubert S; Jossart C; McNicoll N; De Léan A FEBS J; 2005 Nov; 272(21):5572-83. PubMed ID: 16262696 [TBL] [Abstract][Full Text] [Related]
26. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor. Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060 [TBL] [Abstract][Full Text] [Related]
27. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism. Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502 [TBL] [Abstract][Full Text] [Related]
28. Atrial natriuretic peptide receptors on the corneal endothelium. Walkenbach RJ; Ye GS; Korenfeld MS; Boney F Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2538-43. PubMed ID: 8100810 [TBL] [Abstract][Full Text] [Related]
29. HS-142-1, a Novel Non-peptide Antagonist for Atrial Natriuretic Peptide Receptor, Selectively Inhibits Particulate Guanylyl Cyclase and Lowers Cyclic GMP in LLC-PK1 Cells. Tanaka T; Ichimura M; Nakajo S; Snajdar RM; Morishita Y; Sano T; Yamada K; Inagami T; Matsuda Y Biosci Biotechnol Biochem; 1992 Jan; 56(7):1041-5. PubMed ID: 27286374 [TBL] [Abstract][Full Text] [Related]
30. Atrial natriuretic peptide (ANP) inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension. Leskinen H; Vuolteenaho O; Toth M; Ruskoaho H Endocrinology; 1997 May; 138(5):1893-902. PubMed ID: 9112384 [TBL] [Abstract][Full Text] [Related]
31. Comparative effects of activation of soluble and particulate guanylyl cyclase on cyclic GMP elevation and relaxation of bovine tracheal smooth muscle. Ijioma SC; Challiss RA; Boyle JP Br J Pharmacol; 1995 Jul; 115(5):723-32. PubMed ID: 8548169 [TBL] [Abstract][Full Text] [Related]
32. Stable expression of natriuretic peptide receptors: effects of HS-142-1, a non-peptide ANP antagonist. Ohyama Y; Miyamoto K; Morishita Y; Matsuda Y; Saito Y; Minamino N; Kangawa K; Matsuo H Biochem Biophys Res Commun; 1992 Nov; 189(1):336-42. PubMed ID: 1360206 [TBL] [Abstract][Full Text] [Related]
33. Presence of dendroaspis natriuretic peptide and its binding to NPR-A receptor in rabbit kidney. Kim SM; Kim YA; Kim SY; Kim SH; Cho KW; Kim SZ Regul Pept; 2011 Feb; 167(1):42-9. PubMed ID: 21130122 [TBL] [Abstract][Full Text] [Related]
34. HS-142-1 inhibits testosterone production and guanosine-3':5'-cyclic monophosphate accumulation stimulated by atrial natriuretic peptide in isolated mouse Leydig cells. Schumacher H; Matsuda Y; Mukhopadhyay AK Mol Cell Endocrinol; 1993 Jul; 94(1):105-10. PubMed ID: 7690721 [TBL] [Abstract][Full Text] [Related]
35. Identification of renal natriuretic peptide receptor subpopulations by use of the non-peptide antagonist, HS-142-1. Rutherford RA; Matsuda Y; Wilkins MR; Polak JM; Wharton J Br J Pharmacol; 1994 Nov; 113(3):931-9. PubMed ID: 7858888 [TBL] [Abstract][Full Text] [Related]
36. Water deprivation enhances the inhibitory effect of natriuretic peptides on cAMP synthesis in rat renal glomeruli. Woodard GE; Li X; Rosado JA Am J Physiol Renal Physiol; 2004 Sep; 287(3):F418-26. PubMed ID: 15126246 [TBL] [Abstract][Full Text] [Related]
37. Allotopic antagonism of the non-peptide atrial natriuretic peptide (ANP) antagonist HS-142-1 on natriuretic peptide receptor NPR-A. Poirier H; Labrecque J; Deschênes J; DeLéan A Biochem J; 2002 Feb; 362(Pt 1):231-7. PubMed ID: 11829760 [TBL] [Abstract][Full Text] [Related]
38. Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells. Role of cGMP and cGMP-dependent protein kinase. Kumar R; Cartledge WA; Lincoln TM; Pandey KN Hypertension; 1997 Jan; 29(1 Pt 2):414-21. PubMed ID: 9039136 [TBL] [Abstract][Full Text] [Related]